Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52
“Next, Duchemin-Pelletier et al. present data about the role of CK2β, the regulatory subunit of the ubiquitous protein kinase CK2 [16]. In MCF10A mammary epithelial cells where CK2β expression was downregulated, the authors provide evidence that CK2β downregulation can promote the acquisition of characteristics commonly associated with the cancer stem cell phenotype. They demonstrate that a CK2β level establishes a critical cell fate threshold in the control of epithelial cell plasticity. Since EMT supports the induction stem-cell phenotype, identifying the CK2 substrates will improve the discovery of new specific markers for breast cell stemness.”
Conflicts of Interest
References
- Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers 2018, 10, 52. [Google Scholar] [CrossRef] [PubMed]
- Duchemin-Pelletier, E.; Baulard, M.; Spreux, E.; Prioux, M.; Burute, M.; Mograbi, B.; Guyon, L.; Théry, M.; Cochet, C.; Filhol, O. Stem Cell-Like Properties of CK2β-down Regulated Mammary Cells. Cancers 2017, 9. [Google Scholar] [CrossRef] [PubMed]
© 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Roche, J. Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52. Cancers 2018, 10, 79. https://doi.org/10.3390/cancers10030079
Roche J. Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52. Cancers. 2018; 10(3):79. https://doi.org/10.3390/cancers10030079
Chicago/Turabian StyleRoche, Joëlle. 2018. "Erratum: Roche, J. The Epithelial-to-Mesenchymal Transition in Cancer. Cancers, 2018, 10, 52" Cancers 10, no. 3: 79. https://doi.org/10.3390/cancers10030079